Depletion of PRMT5 in glioma cell lines failed to form tumors in mice engrafted intracranially with GBM xenografts13, suggesting that PRMT5 serves as a potential therapeutic target for cancer therapy. This evidence concerns the gene PRMT5 and central nervous system cancer.